Dec 23 (Reuters) – The U.S. Centers for Medicare and Medicaid Services said on Tuesday it will negotiate drug pricing with manufacturers of GLP-1 medications to expand access to the drugs that help with weight loss.
(Reporting by Christy Santhosh in Bengaluru; Editing by Shinjini Ganguli)
Comments